Switch to:

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 7/10

vs
industry
vs
history
Cash to Debt 0.03
DYNT's Cash to Debt is ranked lower than
58% of the 392 Companies
in the Global Medical Devices industry.

( Industry Median: 2.71 vs. DYNT: 0.03 )
DYNT' s 10-Year Cash to Debt Range
Min: 0.01   Max: 0.52
Current: 0.03

0.01
0.52
Equity to Asset 0.42
DYNT's Equity to Asset is ranked higher than
51% of the 373 Companies
in the Global Medical Devices industry.

( Industry Median: 0.62 vs. DYNT: 0.42 )
DYNT' s 10-Year Equity to Asset Range
Min: 0.32   Max: 0.71
Current: 0.42

0.32
0.71
Interest Coverage 0.40
DYNT's Interest Coverage is ranked lower than
62% of the 212 Companies
in the Global Medical Devices industry.

( Industry Median: 81.00 vs. DYNT: 0.40 )
DYNT' s 10-Year Interest Coverage Range
Min: 0.1   Max: 9.02
Current: 0.4

0.1
9.02
F-Score: 3
Z-Score: 2.65
M-Score: -2.92
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 3/10

vs
industry
vs
history
Operating margin (%) 0.36
DYNT's Operating margin (%) is ranked higher than
62% of the 382 Companies
in the Global Medical Devices industry.

( Industry Median: 6.50 vs. DYNT: 0.36 )
DYNT' s 10-Year Operating margin (%) Range
Min: -28.6   Max: 9.38
Current: 0.36

-28.6
9.38
Net-margin (%) -0.15
DYNT's Net-margin (%) is ranked higher than
63% of the 382 Companies
in the Global Medical Devices industry.

( Industry Median: 4.71 vs. DYNT: -0.15 )
DYNT' s 10-Year Net-margin (%) Range
Min: -25.91   Max: 5.88
Current: -0.15

-25.91
5.88
ROE (%) -0.71
DYNT's ROE (%) is ranked higher than
62% of the 377 Companies
in the Global Medical Devices industry.

( Industry Median: 5.57 vs. DYNT: -0.71 )
DYNT' s 10-Year ROE (%) Range
Min: -134.76   Max: 12.28
Current: -0.71

-134.76
12.28
ROA (%) -0.29
DYNT's ROA (%) is ranked higher than
64% of the 392 Companies
in the Global Medical Devices industry.

( Industry Median: 3.23 vs. DYNT: -0.29 )
DYNT' s 10-Year ROA (%) Range
Min: -45.82   Max: 6.25
Current: -0.29

-45.82
6.25
ROC (Joel Greenblatt) (%) 1.01
DYNT's ROC (Joel Greenblatt) (%) is ranked higher than
63% of the 391 Companies
in the Global Medical Devices industry.

( Industry Median: 12.89 vs. DYNT: 1.01 )
DYNT' s 10-Year ROC (Joel Greenblatt) (%) Range
Min: -68.16   Max: 15
Current: 1.01

-68.16
15
Revenue Growth (%) -1.10
DYNT's Revenue Growth (%) is ranked higher than
64% of the 307 Companies
in the Global Medical Devices industry.

( Industry Median: 4.60 vs. DYNT: -1.10 )
DYNT' s 10-Year Revenue Growth (%) Range
Min: -3.6   Max: 37.6
Current: -1.1

-3.6
37.6
EBITDA Growth (%) -21.10
DYNT's EBITDA Growth (%) is ranked higher than
60% of the 282 Companies
in the Global Medical Devices industry.

( Industry Median: -2.90 vs. DYNT: -21.10 )
DYNT' s 10-Year EBITDA Growth (%) Range
Min: 0   Max: 47.9
Current: -21.1

0
47.9
» DYNT's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Oprt. Cash Flow & Free Cash Flow

» Details

Insider Trades

Latest Guru Trades with DYNT

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)



No Insider Trades Found!
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Ratios

vs
industry
vs
history
P/B 1.68
DYNT's P/B is ranked higher than
81% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 3.50 vs. DYNT: 1.68 )
DYNT' s 10-Year P/B Range
Min: 0.54   Max: 3.76
Current: 1.68

0.54
3.76
P/S 0.37
DYNT's P/S is ranked higher than
97% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 3.21 vs. DYNT: 0.37 )
DYNT' s 10-Year P/S Range
Min: 0.11   Max: 1.56
Current: 0.37

0.11
1.56
PFCF 21.21
DYNT's PFCF is ranked higher than
90% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. DYNT: 21.21 )
DYNT' s 10-Year PFCF Range
Min: 3.32   Max: 635
Current: 21.21

3.32
635
EV-to-EBIT -53.02
DYNT's EV-to-EBIT is ranked higher than
53% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 57.01 vs. DYNT: -53.02 )
DYNT' s 10-Year EV-to-EBIT Range
Min: 10.6   Max: 2562.1
Current: -53.02

10.6
2562.1
Current Ratio 1.48
DYNT's Current Ratio is ranked lower than
52% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 2.86 vs. DYNT: 1.48 )
DYNT' s 10-Year Current Ratio Range
Min: 1.43   Max: 7.8
Current: 1.48

1.43
7.8
Quick Ratio 0.59
DYNT's Quick Ratio is ranked lower than
60% of the 273 Companies
in the Global Medical Devices industry.

( Industry Median: 2.12 vs. DYNT: 0.59 )
DYNT' s 10-Year Quick Ratio Range
Min: 0.59   Max: 4.5
Current: 0.59

0.59
4.5

Valuation & Return

vs
industry
vs
history
Price/Tangible Book 1.75
DYNT's Price/Tangible Book is ranked higher than
91% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 6.09 vs. DYNT: 1.75 )
DYNT' s 10-Year Price/Tangible Book Range
Min: 0.75   Max: 6.58
Current: 1.75

0.75
6.58
Price/DCF (Projected) 0.80
DYNT's Price/DCF (Projected) is ranked higher than
97% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 9999.00 vs. DYNT: 0.80 )
DYNT' s 10-Year Price/DCF (Projected) Range
Min: 0.58   Max: 13.15
Current: 0.8

0.58
13.15
Price/Median PS Value 0.88
DYNT's Price/Median PS Value is ranked higher than
87% of the 415 Companies
in the Global Medical Devices industry.

( Industry Median: 1.15 vs. DYNT: 0.88 )
DYNT' s 10-Year Price/Median PS Value Range
Min: 0.31   Max: 6.26
Current: 0.88

0.31
6.26
Forward Rate of Return (Yacktman) -15.94
DYNT's Forward Rate of Return (Yacktman) is ranked higher than
59% of the 314 Companies
in the Global Medical Devices industry.

( Industry Median: 1.43 vs. DYNT: -15.94 )
DYNT' s 10-Year Forward Rate of Return (Yacktman) Range
Min: -12.7   Max: 9.8
Current: -15.94

-12.7
9.8

Business Description

Industry: Medical Devices » Medical Devices
Compare:MDT, SYK, SMA, ZMH, STJ » details
Dynatronics Corporation is a Utah corporation formed on April 29, 1983. The Company manufacture and distribute a line of medical equipment including therapy devices, medical supplies and soft goods, treatment tables and rehabilitation equipment. In addition, it manufactures and distributes a line of aesthetic equipment including aesthetic massage and microdermabrasion devices, as well as skin care products. These products are used mainly by physical therapists, chiropractors, sports medicine practitioners, podiatrists, plastic surgeons, dermatologists, aestheticians and other aesthetic services providers. Therapeutic Ultrasound therapy provides therapeutic deep heat to soft tissue through the introduction of sound waves into the body. It is one of the most common modalities used in physical therapy for treating pain, muscle spasms and joint contractures. The Company markets a line of devices that include electrotherapy, ultrasound or a combination of both of these modalities in a single device. The Dynatron 125 ultrasound and the Dynatron 525 electrotherapy devices target the low-priced segment of the market. The '50 Series Plus' products offer combinations of electrotherapy and ultrasound modalities at a reasonable cost to the practitioner. Infrared Light Therapy is the five Dynatron Solaris units, the Dynatron 702, and the Dynatron X3 and DX2 devices, all feature infrared light therapy technology. These units are capable of powering various cluster probes at different wavelengths for treating a variety of medical conditions including pain and stiffness associated with arthritis, as well as muscle and joint pain. Oscillation Therapy Soft tissue oscillation therapy has been used for the treatment of pain in Europe for over 15 years, yet it is relatively new to the United States market. The Dynatron X5 Oscillation Therapy device creates an electrostatic field within the patient, resulting in an effective treatment for reducing minor muscle aches and pains. Iontophoresis uses electrical current to transdermally deliver drugs such as lidocaine for localized treatment of inflammation without the use of needles. V-Force Vibration Therapy device is developed for the Russian space program to compensate for bone and muscle loss resulting from extended periods in space, whole-body vibration therapy provides neuromuscular training to increase strength, improve balance and enhance flexibility. The Company market its products through direct sales representatives, independent dealers and the new product catalog, and are also continually seeking to update the line of manufactured and distributed medical supplies and soft goods. Dynatron(R) and Dynatron Solaris(R) are registered trademarks owned by Dynatronics. The Company competes with different companies in the different market : domestic competitors in the sale of electrotherapy and ultrasound products are DJO, Naimco, and Mettler Electronics; DJO, Rich-Mar, Erchonia, Anodyne and MedX in lig
» More Articles for DYNT

Headlines

Articles On GuruFocus.com
physical therepy eqi Jan 09 2013 
Dynatronics Corp. Reports Operating Results (10-Q) Nov 12 2010 
Dynatronics Corp. Reports Operating Results (10-Q) May 17 2010 
Dynatronics Corp. Reports Operating Results (10-Q) Feb 01 2010 
Dynatronics Corp. Reports Operating Results (10-Q/A) Aug 27 2009 
Dynatronics Corp. Reports Operating Results (10-K/A) Aug 27 2009 
Dynatronics Corp. Reports Operating Results (10-Q/A) Aug 26 2009 
Dynatronics Corp. Reports Operating Results (10-Q/A) Aug 26 2009 
Dynatronics Corp. Reports Operating Results (10-Q) May 14 2009 
Dynatronics Corp. Reports Operating Results (10-Q) Feb 14 2009 

More From Other Websites
Dynatronics Announces Completion of $3.8 Million Sale and Leaseback Transaction Aug 11 2014
Dynatronics Awarded Sole-Source GPO Contract Jun 12 2014
Dynatronics' (DYNT) CEO Kelvyn Cullimore on Q3 2014 Results - Earnings Call Transcript May 13 2014
Dynatronics Announces Third Quarter Financial Results May 13 2014
Dynatronics To Release Fiscal Third Quarter Results Tuesday, May 13, 2014; Conference Call set for... May 12 2014
Dynatronics Announces Second Quarter Financial Results And Introduction of New ThermoStim Probe Feb 14 2014
Dynatronics To Release Fiscal Second Quarter Results Friday, February 14, 2014; Conference Call set... Feb 12 2014
Dynatronics' CEO Discusses Q1 2014 Results - Earnings Call Transcript Nov 14 2013
Dynatronics Announces First Quarter Financial Results Nov 14 2013
Dynatronics To Release Fiscal First Quarter Results Thursday, November 14, 2013; Nov 11 2013
Dynatronics Corporation's CEO Discusses F4Q 2013 Results - Earnings Call Transcript Sep 30 2013
Dynatronics Announced Changes in Today's Conference Call Monday, September 30, 2013; Conference Call... Sep 30 2013
Dynatronics Announces Year-End Financial Results Sep 30 2013
Dynatronics To Release Fiscal 2013 Year-end Results Monday, September 30, 2013; Conference Call set... Sep 25 2013

Personalized Checklist








Within your circle of competence?
Macro economic environment favorable?
High quality business?
Enough margin of safety with stocks?
Gurus are buying?
Insiders are buying?
Management capable and shareholder friendly?
Catalyst for stock price to appreciate?
Your level of confidence with the research?

Add Notes, Comments or Ask Questions

User Comments

No comment yet

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK